Cost Effectiveness Analysis Of Abiraterone Acetate As Treatment For Metastatic Castration Resistant Prostate Cancer After Failure Of Docetaxel Using Data From Real Life Treatment Praxis In Sweden
Abstract
Authors
U. Persson S. Nilsson C. Prûtz C. Hjortsberg